The Arab Drug Company

Equities

ADCI

EGS38321C013

Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
94.19 ^EGP	0.00%		0.00%	+35.27%

14/02	The Arab Drug Company Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2023	CI

The Arab Drug Company Reports Earnings Results for the Six Months Ended December 31, 2017

February 08, 2018 at 04:13 pm IST

The Arab Drug Company reported earnings results for the six months ended December 31, 2017. For the period, the company reported net profit of EGP 18,392,009 compared to EGP 10,238,482 a year ago.

Latest news about The Arab Drug Company

The Arab Drug Company Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	14/02	CI
The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2023	14/11	CI
The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2022	15/22/15	CI
The Arab Drug Company Reports Earnings Results for the Half Year Ended December 31, 2021	15/22/15	CI
The Arab Drug Company Reports Earnings Results for the First Quarter Ended September 30, 2021	15/21/15	CI
The Arab Drug Company Reports Earnings Results for the Full Year Ended June 30, 2021	01/21/01	CI
The Arab Drug Company Reports Financial Results for the Period from July 1, 2020 to March 31, 2021	20/21/20	CI
The Arab Drug Company Reports Earnings Results for the Six Months Ended December 31, 2020	12/21/12	CI
The Arab Drug Company Announces Unaudited Earnings Results for the Full Year Ended June 30, 2020	12/20/12	CI
The Arab Drug Company Reports its Financial Results for the Period from July 1, 2019 to March 31, 2020	17/20/17	CI
Arab Drug Company Announces Earnings Results for the Nine Months Ended 31 March 2020	13/20/13	CI
The Arab Drug Company Reports Its Financial Results for the Period from July 1, 2019 to September 30, 2019	07/19/07	CI
Arab Pharmaceuticals Announces Earnings Results for the Quarter Ended March 31, 2019	14/19/14	CI
Arab Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2018	11/19/11	CI
Arab Pharmaceuticals Reports Earnings Results for the Quarter Ended September 30, 2018	08/18/08	CI
The Arab Drug Company Announces Cash Dividend, Payable October 28, 2018	09/18/09	CI
Arab Pharmaceuticals Reports Audited Earnings Results for Year Ended June 30, 2018	29/18/29	CI
Arab Pharmaceuticals Announces Earnings Results for the Nine Months Ended March 31, 2018	08/18/08	CI
The Arab Drug Company Reports Earnings Results for the Six Months Ended December 31, 2017	08/18/08	CI
Arab Pharmaceuticals Reports Earnings Results for the First Quarter Ended September 30, 2017	13/17/13	CI
Arab Pharmaceuticals Declares Cash Dividend, Payable on October 26, 2017	10/17/10	CI
The Arab Drug Company Reports Audited Earnings Results for the Year Ended June 30, 2017	07/17/07	CI
Arab Pharmaceuticals Reports Earnings Results for the Nine Months Ended March 31, 2017	14/17/14	CI
Arab Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2016	08/17/08	CI

Chart The Arab Drug Company

Duration

Period

More charts

Company Profile

Arab Drug Company for Pharmaceuticals and Chemical Industries SAE specializes in developing, manufacturing and marketing pharmaceutical and veterinary products.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
THE ARAB DRUG COMPANY	+35.27%	11.98M
ELI LILLY AND COMPANY	+38.59%	727B
JOHNSON & JOHNSON	-7.89%	354B
MERCK & CO., INC.	+15.66%	328B
ABBVIE INC.	+0.24%	277B
ASTRAZENECA PLC	+13.47%	243B
NOVARTIS AG	+7.35%	205B
ROCHE HOLDING AG	-6.42%	203B
AMGEN INC.	+4.23%	164B
PFIZER, INC.	-1.70%	164B

Other Pharmaceuticals